8-K: HeartSciences Merges with Fortitude Mining, Files Proxy Statement

HeartSciences Inc. announced its preliminary proxy statement filing for a business combination with Fortitude Mining Holdings, Inc., alongside its fiscal 2026 financial results and business updates.

Summary

• HeartSciences Inc. has filed a preliminary proxy statement for its proposed business combination with Fortitude Mining Holdings, Inc., an asset mining platform focused on Zcash.
• The company also provided its financial results for the fiscal year ended April 30, 2026, reporting no meaningful revenue and approximately $1.7 million in cash as of April 30, 2026.
• Key business updates include the full commercial launch of the MyoVista Insights platform and the submission of the MyoVista wavECG device to the FDA for 510(k) clearance.
• The proposed transaction with Fortitude is presented as a significant value creation opportunity, leveraging Fortitude's substantial Zcash mining operations and infrastructure.
• Fortitude's new facility in Grand Island, Nebraska, is expected to increase its owned power portfolio to over 60MW and lower Zcash direct cash mining costs.
• A proposal for a potential reverse stock split, ranging from 1-for-2 to 1-for-5, is included, primarily to meet Nasdaq listing requirements for the combined company.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral to slightly positive. While HeartSciences' standalone financial situation is weak, the proposed merger with Fortitude presents a potentially strong growth opportunity in the digital asset mining sector. The success hinges on the completion of the merger and the performance of Zcash.

Positives

• The proposed business combination with Fortitude Mining Holdings is viewed as a significant value creation opportunity for shareholders.
• Fortitude is a substantial operator in the Zcash ecosystem, mining 72,696 ZEC in the six months ended June 30, 2026, representing approximately 28% of overall ZEC production.
• Fortitude's new facility in Grand Island, Nebraska, brings its owned power portfolio to over 60MW, aiming to reduce Zcash mining costs to approximately $40 per coin.
• Fortitude has executed purchase orders for new mining machines with an expected payback of 12-18 months.
• Fortitude estimates its run-rate Adjusted EBITDA could exceed $50 million at Zcash prices above $500.
• The MyoVista Insights platform has been fully launched commercially, with AI-ECG algorithms and deployment contracts with healthcare institutions.
• The MyoVista wavECG device has been submitted to the FDA for 510(k) clearance, which is currently under review.

Negatives

• HeartSciences reported no meaningful revenue for the fiscal year ended April 30, 2026.
• As of April 30, 2026, the company had only $1.7 million in cash and cash equivalents and $0.2 million in shareholders equity.
• The company has experienced sustained pressure on its share price and navigated repeated Nasdaq listing deficiencies.
• The company has often lacked the cash runway for long-term strategic and operational decisions.
• A potential reverse stock split is proposed, which can be viewed negatively by some shareholders.

Risks

• The proposed transaction may not be completed on the anticipated timeline or at all.
• Failure to satisfy closing conditions, including shareholder approval, could prevent the transaction.
• Market or macroeconomic conditions could adversely affect HeartSciences, Fortitude, or the combined company.
• Risks related to the integration of the two companies and management of a newly public entity.
• The highly volatile nature of the price of Zcash and other cryptocurrencies poses a risk to Fortitude's operations.
• Risks related to Nasdaq's review of the combined company's initial listing application.
• Significant legal, commercial, regulatory, and technical uncertainty regarding digital assets generally.

Future Outlook

The company anticipates that the business combination with Fortitude will provide shareholders with ownership in a company operating at scale within the Zcash ecosystem. Fortitude expects its new facility to lower Zcash direct cash mining costs and its new machines to have a payback period of 12-18 months. The MyoVista Insights platform's future strategy involves adding more AI-ECG algorithms and converting customer discussions into contracts. A reverse stock split is a possibility to support Nasdaq listing requirements.

Management Comments

• "Fiscal 2026 was a year of transformational change for HeartSciences. MyoVista Insights moved from development into full commercial use, with our platform launch, our first AI-ECG algorithm and commercial deployments with healthcare institutions, and our MyoVista wavECG device is under FDA review for 510(k) clearance."
• "The proposed combination with Fortitude builds on that progress. It offers our shareholders continued ownership in a business operating at scale and generating meaningful revenue, anchored in Zcash, one of the best-performing large-cap digital assets of the past year."
• "Fortitude is among the largest and longest-tenured operators in the Zcash ecosystem, and we believe the combination represents a significant value creation opportunity."
• "We encourage all shareholders to read the Proxy Statement and look forward to their support at the special meeting."

Industry Context

StockSavvy.ai notes that this filing signifies a strategic pivot for HeartSciences from healthcare IT, specifically AI-ECG, towards the digital asset mining sector through its merger with Fortitude Mining. This move aligns with the increasing institutional interest in cryptocurrencies like Zcash, which offers enhanced privacy and quantum computing resilience compared to Bitcoin. The integration of AI in ECG technology is a growing trend, but HeartSciences' current financial position and past Nasdaq listing challenges appear to have driven this significant strategic shift.

Comparison to Industry Standards

• Fortitude's mining cost target of approximately $40 per ZEC coin is competitive within the digital asset mining industry, aiming to be among the lower cost producers.
• Fortitude's estimated run-rate Adjusted EBITDA of over $50 million at Zcash prices above $500 is a significant figure for a company in the digital asset mining space, though it is a projection.
• The MyoVista Insights platform aims to replicate the success of best-in-class radiology AI platforms in the ECG field, indicating an ambition to meet high industry standards for AI-driven healthcare solutions.
• The expected payback period of 12-18 months for new mining machines is a standard metric used to evaluate capital expenditure efficiency in the mining industry.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential for increased value through the merger with Fortitude, but also risks associated with the transaction's completion and the volatility of digital assets. A reverse stock split may also impact share perception.
• Employees: The merger could lead to changes in organizational structure and strategic direction for HeartSciences employees. Fortitude's employees will be integrated into the combined entity.
• Creditors: The financial health of the combined entity will be crucial. The merger aims to provide a stronger financial footing, potentially benefiting creditors.
• Customers (Healthcare Institutions): The MyoVista Insights platform and MyoVista wavECG device development continues, with potential for future adoption in the healthcare sector.

Next Steps

• Shareholders to review the preliminary proxy statement and other relevant materials filed with the SEC.
• HeartSciences will mail a definitive proxy statement and proxy card to shareholders entitled to vote at the special meeting.
• Shareholders will vote on the Proposed Transaction at a special meeting.
• Completion of the business combination with Fortitude Mining Holdings, subject to approvals and closing conditions.
• Potential implementation of a reverse stock split if deemed necessary for Nasdaq listing requirements.

Key Dates

Recommendation

The filing details a significant strategic shift for HeartSciences towards digital asset mining via a merger with Fortitude. While Fortitude appears to be a substantial operator with promising cost reduction plans, the inherent volatility of Zcash, the complexities of integrating two distinct businesses, and the uncertainties surrounding regulatory environments for digital assets warrant a cautious approach. The company's prior financial struggles and Nasdaq listing issues also add to the risk profile. Therefore, a 'hold' recommendation is appropriate pending further clarity on the merger's completion, the combined entity's operational execution, and the broader digital asset market conditions.

Keywords

HeartSciences, Fortitude Mining Holdings, Zcash, Business Combination, Merger, MyoVista Insights, MyoVista wavECG, FDA 510(k)